Related Experiment Video
Updated: Nov 18, 2025

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
Obesity and atypical depression symptoms: findings from Mendelian randomization in two European cohorts
Giorgio Pistis1, Yuri Milaneschi2, Caroline L Vandeleur3
1Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. giorgio.pistis@chuv.ch.
Abstract:
Studies considering the causal role of body mass index (BMI) for the predisposition of major depressive disorder (MDD) based on a Mendelian Randomization (MR) approach have shown contradictory results. These inconsistent findings may be attributable to the heterogeneity of MDD; in fact, several studies have documented associations between BMI and mainly the atypical subtype of MDD. Using a MR approach, we investigated the potential causal role of obesity in both the atypical subtype and its five specific symptoms assessed according to the Statistical Manual of Mental Disorders (DSM), in two large European cohorts, CoLaus|PsyCoLaus (n = 3350, 1461 cases and 1889 controls) and NESDA|NTR (n = 4139, 1182 cases and 2957 controls). We first tested general obesity measured by BMI and then the body fat distribution measured by waist-to-hip ratio (WHR). Results suggested that BMI is potentially causally related to the symptom increase in appetite, for which inverse variance weighted, simple median and weighted median MR regression estimated slopes were 0.68 (SE = 0.23, p = 0.004), 0.77 (SE = 0.37, p = 0.036), and 1.11 (SE = 0.39, p = 0.004). No causal effect of BMI or WHR was found on the risk of the atypical subtype or for any of the other atypical symptoms. Our findings show that higher obesity is likely causal for the specific symptom of increase in appetite in depressed participants and reiterate the need to study depression at the granular level of its symptoms to further elucidate potential causal relationships and gain additional insight into its biological underpinnings.
Insights
Obesity, measured by body mass index (BMI), may causally increase appetite in individuals with major depressive disorder (MDD). This Mendelian Randomization study highlights the importance of examining depression symptoms individually for deeper biological insights.
Area of Science:
- Psychiatry and Genetics
- Metabolic Health and Mental Well-being
Background:
- Contradictory findings exist regarding the causal link between body mass index (BMI) and major depressive disorder (MDD).
- Previous research suggests BMI is associated with atypical depression, indicating potential heterogeneity in MDD subtypes.
Purpose of the Study:
- To investigate the potential causal role of obesity (BMI and waist-to-hip ratio) in atypical depression and its specific symptoms using a Mendelian Randomization (MR) approach.
- To analyze data from two large European cohorts: CoLaus|PsyCoLaus and NESDA|NTR.
Main Methods:
- Employed Mendelian Randomization (MR) analysis to assess the causal relationship between obesity indicators (BMI, WHR) and atypical depression.
- Utilized data from CoLaus|PsyCoLaus (n=3350) and NESDA|NTR (n=4139) cohorts, including individuals diagnosed with depression.
Main Results:
- A potential causal relationship was identified between higher BMI and an increased appetite symptom in depressed individuals.
- No significant causal effect of BMI or waist-to-hip ratio (WHR) was found on the overall risk of atypical depression or its other specific symptoms.
Conclusions:
- Higher obesity is likely a causal factor for increased appetite in individuals experiencing depression.
- Studying depression at a granular symptom level is crucial for understanding underlying biological mechanisms and potential causal pathways.
Related Concept Videos
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Obesity
Bias in Epidemiological Studies
Bulimia Nervosa
Antidepressant Drugs: MAOIs and Other Agents

